title: [DOXYCYCLINE (UNIDOX SOLUTAB®) AND/OR JOSAMYCIN (WILPRAFEN®) IN TREATMENT OF PATIENTS WITH PROSTATITIS IN REAL CLINICAL PRACTICE. RESULTS OF THE TAURUS OBSERVATIONAL PROGRAM].
abstract: Treatment of chronic prostatitis is a vital and complicated problem, in which a large number of stamps and "stereotyped" approaches often result in uncured patients. The increasing use of intracellular microorganisms in prostatitis etiology requires a modification in the standard approaches. TAURUS study shows high efficacy of doxycycline (Unidox Solutab®) and/or josamycin (Wilprafen®) in chronic prostatitis. Therapy, studied in this program, according to physicians, was effective in 93.2% of patients. Treatment failure was observed in 1.3% of all patients, another 5.5% of patients had insufficient data for assessment. Low incidence of adverse reactions was observed. In the study population, adverse reactions occurred in 2.6% of patients, of them serious adverse events were registered in 0.7% of patients. The most common adverse event in all treatment groups was diarrhea.
authors.forename: A Z
authors.initials: AZ
authors.lastname: Vinarov
authors.forename: S V
authors.initials: SV
authors.lastname: Stojlov
authors.forename: S V
authors.initials: SV
authors.lastname: Kozyrev
authors.forename: V N
authors.initials: VN
authors.lastname: Surikov
authors.forename: A V
authors.initials: AV
authors.lastname: Chaban
authors.forename: D G
authors.initials: DG
authors.lastname: Kurbatov
authors.forename: E S
authors.initials: ES
authors.lastname: Shpilenja
authors.forename: A I
authors.initials: AI
authors.lastname: Nejmark
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004318:Doxycycline / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D015570:Josamycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D011446:Prospective Studies; D011472:Prostatitis / Q000188:drug therapy* / Q000382:microbiology / Q000523:psychology; D011788:Quality of Life; D011795:Surveys and Questionnaires
chemical_list: D000900:Anti-Bacterial Agents; D015570:Josamycin; D004318:Doxycycline